全髋关节置换术中血浆和尿液中的凝血酶原片段F1+2
Prothrombin fragment F1+2 in plasma and urine during total hip arthroplasty.
作者信息
Borgen Pål O, Reikeras Olav
机构信息
Department of Orthopedics, Martina Hansens Hospital, Norway.
Department of Orthopedics, Oslo University Hospital, Rikshospitalet, Norway.
出版信息
J Orthop. 2017 Aug 3;14(4):475-479. doi: 10.1016/j.jor.2017.08.001. eCollection 2017 Dec.
Abstract
OBJECTIVE
To study the time course and correlation of prothrombin fragment (F1 + 2) in plasma and urine during THA.
METHOD
F1 + 2 concentrations were recorded at four time-points during THA.
RESULTS
F1 + 2 increased during surgery. In contrast to urine, plasma F1 + 2 was temporarily reduced the first postoperative day. At day six, plasma F1 + 2 was significantly elevated indicating on-going thrombin activation, while urine F1 + 2 was normalized.
CONCLUSION
The response in coagulation to operative trauma can be recorded with F1 + 2 both in plasma and urine. We were not able to demonstrate any correlation of F1 + 2 in plasma and urine later in the postoperative period.
摘要
目的
研究全髋关节置换术（THA）期间血浆和尿液中凝血酶原片段（F1 + 2）的时间进程及相关性。
方法
在THA期间的四个时间点记录F1 + 2浓度。
结果
手术期间F1 + 2升高。与尿液不同，术后第一天血浆F1 + 2暂时降低。在第六天，血浆F1 + 2显著升高，表明凝血酶持续激活，而尿液F1 + 2恢复正常。
结论
血浆和尿液中的F1 + 2均可记录凝血对手术创伤的反应。我们未能证明术后后期血浆和尿液中F1 + 2之间存在任何相关性。
相似文献
1
Prothrombin fragment F1+2 in plasma and urine during total hip arthroplasty.全髋关节置换术中血浆和尿液中的凝血酶原片段F1+2
J Orthop. 2017 Aug 3;14(4):475-479. doi: 10.1016/j.jor.2017.08.001. eCollection 2017 Dec.
2
Biomarkers of Coagulation and Fibrinolysis during Cemented Total Hip Arthroplasty with Pre- versus Postoperative Start of Thromboprophylaxis.骨水泥型全髋关节置换术中术前与术后开始血栓预防时的凝血和纤溶生物标志物
Thrombosis. 2013;2013:563217. doi: 10.1155/2013/563217. Epub 2013 Dec 16.
3
Prothrombin fragment 1+2 in urine as an indicator of sustained coagulation activation after total hip arthroplasty.尿中凝血酶原片段1+2作为全髋关节置换术后持续凝血激活的指标。
Thromb Res. 2007;121(3):369-76. doi: 10.1016/j.thromres.2007.05.002. Epub 2007 Jun 27.
4
Thrombosis markers in hip versus knee arthroplasty: a pilot study.髋关节置换术与膝关节置换术中的血栓形成标志物：一项试点研究。
J Orthop Surg (Hong Kong). 2009 Dec;17(3):291-5. doi: 10.1177/230949900901700309.
5
6
Preoperative plasma levels of prothrombin fragment 1 + 2 correlate with the risk of venous thrombosis after elective hip replacement.
Acta Orthop Belg. 1999 Mar;65(1):39-43.
7
Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery.凝血激活标志物在择期髋关节手术后静脉血栓形成预测中的作用
Thromb Haemost. 1997 Feb;77(2):267-9.
8
Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation.弥散性血管内凝血患者血浆中凝血酶原片段1+2与凝血酶-抗凝血酶III复合物的比较。
Blood Coagul Fibrinolysis. 1992 Dec;3(6):813-8. doi: 10.1097/00001721-199212000-00037.
9
Monitoring thrombin generation with prothrombin fragment 1.2 assay during cardiopulmonary bypass surgery.在体外循环手术期间用凝血酶原片段1.2检测法监测凝血酶生成
Thromb Res. 1996 Oct 1;84(1):45-54. doi: 10.1016/0049-3848(96)00160-0.
引用本文的文献
1
Biomarkers in Venous Thrombosis: Diagnostic Potential and Limitations.静脉血栓形成中的生物标志物：诊断潜力与局限性
Biology (Basel). 2025 Jul 1;14(7):800. doi: 10.3390/biology14070800.
2
Thrombotic Pathogenesis and Laboratory Diagnosis in Cancer Patients, An Update.癌症患者的血栓形成机制与实验室诊断：最新进展
Int J Gen Med. 2023 Jan 22;16:259-272. doi: 10.2147/IJGM.S385772. eCollection 2023.
3
An in situ inferior vena cava ligation-stenosis model to study thrombin generation rates with flow.一种用于研究血流状态下凝血酶生成速率的原位下腔静脉结扎-狭窄模型。
Thromb J. 2022 May 25;20(1):30. doi: 10.1186/s12959-022-00391-1.
4
Predictors and Biomarkers of Subclinical Leaflet Thrombosis after Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术后亚临床瓣叶血栓形成的预测因素和生物标志物
J Clin Med. 2020 Nov 21;9(11):3742. doi: 10.3390/jcm9113742.
本文引用的文献
1
D-Dimer and prothrombin fragment 1 + 2 in urine and plasma in patients with clinically suspected venous thromboembolism.临床疑似静脉血栓栓塞症患者尿液和血浆中的D-二聚体及凝血酶原片段1+2
Blood Coagul Fibrinolysis. 2016 Jun;27(4):396-400. doi: 10.1097/MBC.0000000000000461.
2
Thrombin split products (prothrombin fragment 1 + 2) in urine in patients with suspected deep vein thrombosis admitted for radiological verification.疑似深静脉血栓形成患者入院行影像学检查，检测尿液中凝血酶裂解产物（凝血酶原片段 1+2）。
Thromb Res. 2013 Jun;131(6):560-3. doi: 10.1016/j.thromres.2013.04.019. Epub 2013 May 13.
3
Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.骨科手术患者静脉血栓栓塞症的预防：抗血栓治疗和血栓预防，第 9 版：美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e278S-e325S. doi: 10.1378/chest.11-2404.
4
A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty.髋关节和膝关节置换术患者静脉血栓栓塞预防试验中报告的出血事件的批判性评价。
J Thromb Haemost. 2010 Sep;8(9):1966-75. doi: 10.1111/j.1538-7836.2010.03965.x.
5
Thrombosis markers in hip versus knee arthroplasty: a pilot study.髋关节置换术与膝关节置换术中的血栓形成标志物：一项试点研究。
J Orthop Surg (Hong Kong). 2009 Dec;17(3):291-5. doi: 10.1177/230949900901700309.
6
Differences in urinary prothrombin fragment 1 + 2 levels after total hip replacement in relation to venous thromboembolism and bleeding events.全髋关节置换术后尿凝血酶原片段1+2水平与静脉血栓栓塞及出血事件的关系差异
J Thromb Haemost. 2008 Oct;6(10):1671-9. doi: 10.1111/j.1538-7836.2008.03120.x. Epub 2008 Aug 1.
7
Prothrombin fragment 1+2 in urine as an indicator of sustained coagulation activation after total hip arthroplasty.尿中凝血酶原片段1+2作为全髋关节置换术后持续凝血激活的指标。
Thromb Res. 2007;121(3):369-76. doi: 10.1016/j.thromres.2007.05.002. Epub 2007 Jun 27.
8
Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin.髋关节置换术后持续的血栓前状态：达肝素延长预防的影响
J Thromb Haemost. 2003 May;1(5):971-5. doi: 10.1046/j.1538-7836.2003.00111.x.
9
Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.择期髋关节置换术后患者应用低分子量肝素预防深静脉血栓形成的初始给药时机：一项系统评价
Arch Intern Med. 2001 Sep 10;161(16):1952-60. doi: 10.1001/archinte.161.16.1952.
Zotero 插件